Sanodyne Therapeutics Overview

  • Year Founded
  • 2025

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.38M

  • Investors
  • 2

Sanodyne Therapeutics General Information

Description

Developer of biotech-driven pain management treatments designed to support individuals affected by peripheral neuropathy and chronic pain. The company pioneers breakthrough therapies that address the root causes of nerve damage, enabling patients to enhance well-being and improve long-term quality of life.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 7 Floor, Nihonbashi Muromachi Mitsui Tower
  • 3-2-1 Nihonbashi Muromachi Chuo
  • Tokyo, 103-0022
  • Japan
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 7 Floor, Nihonbashi Muromachi Mitsui Tower
  • 3-2-1 Nihonbashi Muromachi Chuo
  • Tokyo, 103-0022
  • Japan

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanodyne Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 05-Jun-2025 $1.38M Completed Clinical Trials - Phase 1
To view Sanodyne Therapeutics’s complete valuation and funding history, request access »

Sanodyne Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
S1 Shares
To view Sanodyne Therapeutics’s complete cap table history, request access »

Sanodyne Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
JIC Venture Growth Investments Venture Capital Minority
Remiges Ventures Venture Capital Minority
To view Sanodyne Therapeutics’s complete investors history, request access »

Sanodyne Therapeutics FAQs

  • When was Sanodyne Therapeutics founded?

    Sanodyne Therapeutics was founded in 2025.

  • Where is Sanodyne Therapeutics headquartered?

    Sanodyne Therapeutics is headquartered in Tokyo, Japan.

  • What industry is Sanodyne Therapeutics in?

    Sanodyne Therapeutics’s primary industry is Drug Discovery.

  • Is Sanodyne Therapeutics a private or public company?

    Sanodyne Therapeutics is a Private company.

  • What is the current valuation of Sanodyne Therapeutics?

    The current valuation of Sanodyne Therapeutics is .

  • What is Sanodyne Therapeutics’s current revenue?

    The current revenue for Sanodyne Therapeutics is .

  • How much funding has Sanodyne Therapeutics raised over time?

    Sanodyne Therapeutics has raised $1.38M.

  • Who are Sanodyne Therapeutics’s investors?

    JIC Venture Growth Investments and Remiges Ventures have invested in Sanodyne Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process